TrialEuropean journal of heart failure2015

Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial.

Stefan D Anker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.